An Israeli company called Brainsway has developed a transcranial magnetic stimulation (TMS) method using multiple coils that stimulates areas deeper areas in the brain associated with depression and other neurological disorders, providing a possible treatment for patients with major depression who fail to respond to antidepressants.

Brainsway is designing different coils to tackle brain regions associated with other conditions, such as post-traumatic stress disorder, autism, and drug addiction.